Volume 65 Received 23 January 2009 | ||||||||||
| ||||||||||
aFaculty of Science, Chemistry Department, Islamic University of Gaza, Gaza Strip, Palestinian Territories,bInstitute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Eberhard-Karls-University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany, and cDepartment of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55099 Mainz, Germany
Correspondence e-mail: stefan.laufer@uni-tuebingen.de
In the crystal structure of the title compound, C15H11FN2, the pyrrole ring makes dihedral angles of 33.19 (9) and 36.33 (10)° with the pyridine and 4-fluorophenyl rings, respectively. The pyridine ring makes a dihedral angle of 46.59 (9)° with the 4-fluorophenyl ring. In the crystal structure, an N-H
N hydrogen bond joins the molecules into chains.
Many 1-(4-fluorophenyl)-2-(pyridin-4-yl)pyrrol derivatives have been prepared and their biological activities studied; see: de Laszlo et al. (1998
); Revesz et al. (2000
, 2002
); Qian et al. (2006
). For the synthesis of the title compound, see: Qian et al. (2006
).
|
|
|
| |||||||||||||||||
Data collection: CAD-4 Software (Enraf-Nonius, 1989
); cell refinement: CAD-4 Software; data reduction: CORINC (Dräger & Gattow, 1971
); program(s) used to solve structure: SIR97 (Altomare et al., 1999
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: PLATON (Spek, 2003
); software used to prepare material for publication: PLATON.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BT2858 ).
The authors thank the Alexander von Humbolt Foundation (AvH) for funding.
Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.
![[details]](../../../../../../j/graphics/details.gif)
Dräger, M. & Gattow, G. (1971). Acta Chem. Scand. 25, 761-762.
Enraf-Nonius (1989). CAD-4 Software. Enraf-Nonius, Delft, The Netherlands.
Laszlo, S. E. de, Visco, D., Agarwal, L., Chang, L., Chin, J., Croft, G., Forsyth, A., Fletcher, D., Frantz, B., Hacker, C., Hanlon, W., Harper, C., Kostura, M., Li, B., Luell, S., MacCoss, M., Mantlo, N., O'Neill, E. A., Orevillo, C., Pang, M., Parsons, J., Rolando, A., Sahly, Y., Sidler, K., Widmer, W. R. & O'Keefe, S. J. (1998). Bioorg. Med. Chem. Lett. 8, 2689-2694. ![[PubMed]](../../../../../../logos/pubmedborder.gif)
Qian, X., Liang, G.-B., Feng, D., Fisher, M., Crumley, T., Rattray, S., Dulski, P. M., Gurnett, A., Leavitt, P. S., Liberator, P. A., Misura, A. S., Samaras, S., Tamas, T., Schmatz, D. M., Wyvratt, M. & Biftu, T. (2006). Bioorg. Med. Chem. Lett. 16, 2817-2821.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Revesz, L., Di Padova, F. E., Buhl, T., Feifel, R., Gram, H., Hiestand, P., Manning, U., Wolf, R. & Zimmerlin, A. G. (2002). Bioorg. Med. Chem. Lett. 12, 2109-2112.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Revesz, L., Di Padova, F. E., Buhl, T., Feifel, R., Gram, H., Hiestand, P., Manning, U. & Zimmerlin, A. G. (2000). Bioorg. Med. Chem. Lett. 10, 1261-1264.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.
![[details]](../../../../../../j/graphics/details.gif)